These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36778355)

  • 1. Pharmacokinetics of Cannabidiol: A systematic review and meta-regression analysis.
    Moazen-Zadeh E; Chisholm A; Bachi K; Hurd YL
    medRxiv; 2023 Feb; ():. PubMed ID: 36778355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of Cannabidiol: A Systematic Review and Meta-Regression Analysis.
    Moazen-Zadeh E; Chisholm A; Bachi K; Hurd YL
    Cannabis Cannabinoid Res; 2023 Aug; ():. PubMed ID: 37643301
    [No Abstract]   [Full Text] [Related]  

  • 3. A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects.
    Crockett J; Critchley D; Tayo B; Berwaerts J; Morrison G
    Epilepsia; 2020 Feb; 61(2):267-277. PubMed ID: 32012251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
    Taylor L; Gidal B; Blakey G; Tayo B; Morrison G
    CNS Drugs; 2018 Nov; 32(11):1053-1067. PubMed ID: 30374683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy.
    Birnbaum AK; Karanam A; Marino SE; Barkley CM; Remmel RP; Roslawski M; Gramling-Aden M; Leppik IE
    Epilepsia; 2019 Aug; 60(8):1586-1592. PubMed ID: 31247132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Cannabidiol in Sprague-Dawley Rats After Oral and Pulmonary Administration.
    Schwotzer D; Kulpa J; Trexler K; Dye W; Jantzi J; Irshad H; Ware MA; Bonn-Miller M; McDonald J; Lefever T
    Cannabis Cannabinoid Res; 2023 Apr; 8(2):360-373. PubMed ID: 36301522
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic of two oral doses of a 1:20 THC:CBD
    Lyons C; McEwan K; Munn-Patterson M; Vuong S; Alcorn J; Chicoine A
    Front Vet Sci; 2024; 11():1352495. PubMed ID: 38585296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics and bioavailability of monomethyl fumarate following a single oral dose of Bafiertam® (monomethyl fumarate) versus Vumerity® (diroximel fumarate).
    Rousseau FS; Wang L; Sprague TN; Lategan TW; Berkovich RR
    Mult Scler Relat Disord; 2023 Feb; 70():104500. PubMed ID: 36645997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex Differences in the Pharmacokinetics of Cannabidiol and Metabolites Following Oral Administration of a Cannabidiol-Dominant Cannabis Oil in Healthy Adults.
    MacNair L; Kulpa J; Hill ML; Eglit GML; Mosesova I; Bonn-Miller MO; Peters EN
    Cannabis Cannabinoid Res; 2023 Jun; ():. PubMed ID: 37267269
    [No Abstract]   [Full Text] [Related]  

  • 11. A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History.
    Berl V; Hurd YL; Lipshutz BH; Roggen M; Mathur EJ; Evans M
    Cannabis Cannabinoid Res; 2022 Dec; 7(6):777-789. PubMed ID: 35787693
    [No Abstract]   [Full Text] [Related]  

  • 12. A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans.
    Millar SA; Stone NL; Yates AS; O'Sullivan SE
    Front Pharmacol; 2018; 9():1365. PubMed ID: 30534073
    [No Abstract]   [Full Text] [Related]  

  • 13. A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray.
    Stott CG; White L; Wright S; Wilbraham D; Guy GW
    Eur J Clin Pharmacol; 2013 May; 69(5):1135-47. PubMed ID: 23179176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies.
    Silmore LH; Willmer AR; Capparelli EV; Rosania GR
    Pharmacotherapy; 2021 Apr; 41(4):405-420. PubMed ID: 33583102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray.
    Stott CG; White L; Wright S; Wilbraham D; Guy GW
    Eur J Clin Pharmacol; 2013 Apr; 69(4):825-34. PubMed ID: 23052407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
    Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
    J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers.
    Atsmon J; Cherniakov I; Izgelov D; Hoffman A; Domb AJ; Deutsch L; Deutsch F; Heffetz D; Sacks H
    J Pharm Sci; 2018 May; 107(5):1423-1429. PubMed ID: 29287930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and Tolerability of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate and Glycopyrronium/Formoterol Fumarate Dihydrate Metered Dose Inhalers in Healthy Chinese Adults: A Randomized, Double-blind, Parallel-group Study.
    Chen Q; Hu C; Yu H; Shen K; Assam PN; Gillen M; Liu Y; Dorinsky P
    Clin Ther; 2019 May; 41(5):897-909.e1. PubMed ID: 30982547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cannabidiol following single oral and oral transmucosal administration in dogs.
    Della Rocca G; Paoletti F; Conti MB; Galarini R; Chiaradia E; Sforna M; Dall'Aglio C; Polisca A; Di Salvo A
    Front Vet Sci; 2022; 9():1104152. PubMed ID: 36686155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study.
    Devinsky O; Kraft K; Rusch L; Fein M; Leone-Bay A
    J Pharm Sci; 2021 Dec; 110(12):3946-3952. PubMed ID: 34400185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.